Unique statistical approach lends promise to therapies for rare childhood brain cancer
- Jan 19
- 1 min read
Researchers at the University of Louisville used a modern statistical method to reanalyze the results of children with a special type of high-risk medulloblastoma called Group 3, who participated in two major national clinical trials of therapies.

